141 related articles for article (PubMed ID: 20674206)
1. Focal ground-glass opacities in non-small cell lung carcinoma resection patients.
Koo CW; Miller WT; Kucharczuk JC
Eur J Radiol; 2012 Jan; 81(1):139-45. PubMed ID: 20674206
[TBL] [Abstract][Full Text] [Related]
2. Multiple focal pure ground-glass opacities on high-resolution CT images: Clinical significance in patients with lung cancer.
Tsutsui S; Ashizawa K; Minami K; Tagawa T; Nagayasu T; Hayashi T; Uetani M
AJR Am J Roentgenol; 2010 Aug; 195(2):W131-8. PubMed ID: 20651172
[TBL] [Abstract][Full Text] [Related]
3. CT characteristics of resolving ground-glass opacities in a lung cancer screening programme.
Felix L; Serra-Tosio G; Lantuejoul S; Timsit JF; Moro-Sibilot D; Brambilla C; Ferretti GR
Eur J Radiol; 2011 Mar; 77(3):410-6. PubMed ID: 19804950
[TBL] [Abstract][Full Text] [Related]
4. The long-term course of ground-glass opacities detected on thin-section computed tomography.
Lee SW; Leem CS; Kim TJ; Lee KW; Chung JH; Jheon S; Lee JH; Lee CT
Respir Med; 2013 Jun; 107(6):904-10. PubMed ID: 23514949
[TBL] [Abstract][Full Text] [Related]
5. Natural History of Ground-Glass Lesions Among Patients With Previous Lung Cancer.
Shewale JB; Nelson DB; Rice DC; Sepesi B; Hofstetter WL; Mehran RJ; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Antonoff MB
Ann Thorac Surg; 2018 Jun; 105(6):1671-1677. PubMed ID: 29432718
[TBL] [Abstract][Full Text] [Related]
6. Surgical Management of Multifocal Ground-Glass Opacities of the Lung: Correlation of Clinicopathologic and Radiologic Findings.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Thorac Cardiovasc Surg; 2017 Mar; 65(2):142-149. PubMed ID: 26902328
[No Abstract] [Full Text] [Related]
7. Radiographic imaging of bronchioloalveolar carcinoma: screening, patterns of presentation and response assessment.
Gandara DR; Aberle D; Lau D; Jett J; Akhurst T; Heelan R; Mulshine J; Berg C; Patz EF
J Thorac Oncol; 2006 Nov; 1(9 Suppl):S20-6. PubMed ID: 17409997
[TBL] [Abstract][Full Text] [Related]
8. A dominant adenocarcinoma with multifocal ground glass lesions does not behave as advanced disease.
Gu B; Burt BM; Merritt RE; Stephanie S; Nair V; Hoang CD; Shrager JB
Ann Thorac Surg; 2013 Aug; 96(2):411-8. PubMed ID: 23806231
[TBL] [Abstract][Full Text] [Related]
9. Fate of newly detected lesions during postoperative surveillance for non-small cell lung cancer.
Lee JI; Lee YJ; Park KY; Park CH; Jeon YB; Choi CH; Ko KP
Ann Thorac Surg; 2013 Jun; 95(6):1867-71. PubMed ID: 23643548
[TBL] [Abstract][Full Text] [Related]
10. Ground-glass opacity lesions on computed tomography during postoperative surveillance for primary non-small cell lung cancer.
Haro A; Yano T; Kohno M; Yoshida T; Okamoto T; Maehara Y
Lung Cancer; 2012 Apr; 76(1):56-60. PubMed ID: 21945659
[TBL] [Abstract][Full Text] [Related]
11. Nodular ground-glass opacities on thin-section CT: size change during follow-up and pathological results.
Lee HJ; Goo JM; Lee CH; Yoo CG; Kim YT; Im JG
Korean J Radiol; 2007; 8(1):22-31. PubMed ID: 17277560
[TBL] [Abstract][Full Text] [Related]
12. Survival and risk factors for progression after resection of the dominant tumor in multifocal, lepidic-type pulmonary adenocarcinoma.
Gao RW; Berry MF; Kunder CA; Khuong AA; Wakelee H; Neal JW; Backhus LM; Shrager JB
J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2092-2099.e2. PubMed ID: 28863952
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes.
Mattonen SA; Palma DA; Haasbeek CJ; Senan S; Ward AD
Acta Oncol; 2013 Jun; 52(5):910-8. PubMed ID: 23106174
[TBL] [Abstract][Full Text] [Related]
14. Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma.
Kim HK; Choi YS; Kim J; Shim YM; Lee KS; Kim K
J Thorac Oncol; 2010 Feb; 5(2):206-10. PubMed ID: 19901852
[TBL] [Abstract][Full Text] [Related]
15. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K
Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519
[TBL] [Abstract][Full Text] [Related]
16. Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance.
Lou F; Huang J; Sima CS; Dycoco J; Rusch V; Bach PB
J Thorac Cardiovasc Surg; 2013 Jan; 145(1):75-81; discussion 81-2. PubMed ID: 23127371
[TBL] [Abstract][Full Text] [Related]
17. Survival of a surgical series of lung cancer patients with synchronous multiple ground-glass opacities, and the management of their residual lesions.
Shimada Y; Saji H; Otani K; Maehara S; Maeda J; Yoshida K; Kato Y; Hagiwara M; Kakihana M; Kajiwara N; Ohira T; Akata S; Ikeda N
Lung Cancer; 2015 May; 88(2):174-80. PubMed ID: 25758554
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of resected solid-type small-sized c-stage IA non-small cell lung cancer.
Inoue M; Minami M; Sawabata N; Utsumi T; Kadota Y; Shigemura N; Okumura M
Eur J Cardiothorac Surg; 2010 Jun; 37(6):1445-9. PubMed ID: 20137967
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
20. Management of ground-glass opacity lesions detected in patients with otherwise operable non-small cell lung cancer.
Kim HK; Choi YS; Kim K; Shim YM; Jeong SY; Lee KS; Kwon OJ; Kim J
J Thorac Oncol; 2009 Oct; 4(10):1242-6. PubMed ID: 19687762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
